Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
EIKN

Updated 10/6/2026, 8:56 AM ET.

EIKN

Eikon Therapeutics, Inc.

Buy$1,031,045

Column Group IV GP, LP

10% owner

and 7 others

89,200 shat $11.56Filed Sep 8, 4:33 PM ETFiling

Read from public SEC filings. Not financial advice.